schliessen

Filtern

 

Bibliotheken

Prevalence and outcomes of re-positive nucleic acid tests in discharged COVID-19 patients

The prevalence and outcomes of patients who had re-activation of coronavirus disease 2019 (COVID-19) after discharge remain poorly understood. We included 126 consecutively confirmed cases of COVID-19 with 2-month follow-up data after discharge in this retrospective study. The upper respiratory spec... Full description

Journal Title: European journal of clinical microbiology & infectious diseases 2020-08-31, Vol.40 (2), p.413-417
Main Author: Du, Hou-wei
Other Authors: Chen, Jun-nian , Pan, Xiao-bin , Chen, Xiao-ling , Yixian-Zhang , Fang, Shuang-fang , Li, Xiao-qing , Xia, Pin-cang , Gao, Lei , Lin, Hai-long , Chen, Li-min , Liu, Nan
Format: Electronic Article Electronic Article
Language: English
Subjects:
Publisher: Berlin/Heidelberg: Springer Berlin Heidelberg
ID: ISSN: 0934-9723
Link: https://www.ncbi.nlm.nih.gov/pubmed/32865669
Zum Text:
SendSend as email Add to Book BagAdd to Book Bag
Staff View
recordid: cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_7456660
title: Prevalence and outcomes of re-positive nucleic acid tests in discharged COVID-19 patients
format: Article
creator:
  • Du, Hou-wei
  • Chen, Jun-nian
  • Pan, Xiao-bin
  • Chen, Xiao-ling
  • Yixian-Zhang
  • Fang, Shuang-fang
  • Li, Xiao-qing
  • Xia, Pin-cang
  • Gao, Lei
  • Lin, Hai-long
  • Chen, Li-min
  • Liu, Nan
subjects:
  • Aged
  • Biomedical and Life Sciences
  • Biomedicine
  • Brief Report
  • Communicable diseases
  • Coronavirus disease 2019
  • Coronaviruses
  • COVID-19
  • COVID-19 - virology
  • Female
  • Follow-up
  • Humans
  • Infectivity
  • Internal Medicine
  • Male
  • Medical colleges
  • Medical Microbiology
  • Medical research
  • Medicine, Experimental
  • Middle Aged
  • Nucleic acids
  • Outcome
  • Patient Discharge
  • Patient outcomes
  • Polymerase chain reaction
  • Prevalence
  • Re-positive
  • Retrospective Studies
  • Reverse Transcriptase Polymerase Chain Reaction
  • RNA, Viral - analysis
  • SARS-CoV-2 - genetics
  • SARS-CoV-2 - isolation & purification
  • Viral diseases
  • Viruses
ispartof: European journal of clinical microbiology & infectious diseases, 2020-08-31, Vol.40 (2), p.413-417
description: The prevalence and outcomes of patients who had re-activation of coronavirus disease 2019 (COVID-19) after discharge remain poorly understood. We included 126 consecutively confirmed cases of COVID-19 with 2-month follow-up data after discharge in this retrospective study. The upper respiratory specimen using a reverse-transcription polymerase chain reaction test of three patients (71 years [60–76]) were positive within 11–20 days after their discharge, with an event rate of 19.8 (95%CI 2.60–42.1) per 1,000,000 patient-days. Moreover, all re-positive patients were asymptomatic. Our findings suggest that few recovered patients may still be virus carriers even after reaching the discharge criteria.
language: eng
source:
identifier: ISSN: 0934-9723
fulltext: no_fulltext
issn:
  • 0934-9723
  • 1435-4373
url: Link


@attributes
NO1
SEARCH_ENGINEprimo_central_multiple_fe
SEARCH_ENGINE_TYPEPrimo Central Search Engine
RANK2.6216478
LOCALfalse
PrimoNMBib
record
control
sourceidgale_pubme
recordidTN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_7456660
sourceformatXML
sourcesystemPC
galeidA649215926
sourcerecordidA649215926
originalsourceidFETCH-LOGICAL-c440t-bae03971dfd18dc6012bc81f39b377a056544178904d42d582584043adfef440
addsrcrecordideNp9kl9rFDEUxYModrv6BXyQgC--TM2_mUxehLJaLRTqQxF8CtnkzjZlNlmTmQW_vbduba2IBBK4-d1zOZdDyCvOTjhj-l3F23QNE6xhignV8CdkwZVsGyW1fEoWzEjVGC3kETmu9YZhU6_1c3IkRd-1XWcW5NuXAns3QvJAXQo0z5PPW6g0D7RAs8s1TnEPNM1-hOip8zHQCepUaUw0xOqvXdlAoKvLr-cfGm7ozk0R0lRfkGeDGyu8vHuX5Ors49Xqc3Nx-el8dXrReKXY1KwdMGk0D0PgffAd42Ltez5Is5ZaO9Z2rVJc94apoERoe9H2iinpwgADKizJ-4Psbl5vIXgcXdxodyVuXflhs4v28U-K13aT91Yr3EDHUODtnUDJ32d0ZrfoCsbRJchztULJ3hjZC4Hom7_QmzyXhO6Q0kYIrrh5oDa4VxvTkHGuvxW1p50ygrdGdEid_IPCE2AbfU4wRKw_ahCHBl9yrQWGe4-c2ds82EMeLObB_soDVpfk9Z_buW_5HQAE5AGo-JU2UB4s_Uf2J_wZvgc
sourcetypeOpen Access Repository
isCDItrue
recordtypearticle
pqid2479221419
display
typearticle
titlePrevalence and outcomes of re-positive nucleic acid tests in discharged COVID-19 patients
creatorDu, Hou-wei ; Chen, Jun-nian ; Pan, Xiao-bin ; Chen, Xiao-ling ; Yixian-Zhang ; Fang, Shuang-fang ; Li, Xiao-qing ; Xia, Pin-cang ; Gao, Lei ; Lin, Hai-long ; Chen, Li-min ; Liu, Nan
creatorcontribDu, Hou-wei ; Chen, Jun-nian ; Pan, Xiao-bin ; Chen, Xiao-ling ; Yixian-Zhang ; Fang, Shuang-fang ; Li, Xiao-qing ; Xia, Pin-cang ; Gao, Lei ; Lin, Hai-long ; Chen, Li-min ; Liu, Nan ; Fujian Medical Team Support Wuhan for COVID-19 ; On behalf of Fujian Medical Team Support Wuhan for COVID-19
descriptionThe prevalence and outcomes of patients who had re-activation of coronavirus disease 2019 (COVID-19) after discharge remain poorly understood. We included 126 consecutively confirmed cases of COVID-19 with 2-month follow-up data after discharge in this retrospective study. The upper respiratory specimen using a reverse-transcription polymerase chain reaction test of three patients (71 years [60–76]) were positive within 11–20 days after their discharge, with an event rate of 19.8 (95%CI 2.60–42.1) per 1,000,000 patient-days. Moreover, all re-positive patients were asymptomatic. Our findings suggest that few recovered patients may still be virus carriers even after reaching the discharge criteria.
identifier
0ISSN: 0934-9723
1EISSN: 1435-4373
2DOI: 10.1007/s10096-020-04024-1
3PMID: 32865669
languageeng
publisherBerlin/Heidelberg: Springer Berlin Heidelberg
subjectAged ; Biomedical and Life Sciences ; Biomedicine ; Brief Report ; Communicable diseases ; Coronavirus disease 2019 ; Coronaviruses ; COVID-19 ; COVID-19 - virology ; Female ; Follow-up ; Humans ; Infectivity ; Internal Medicine ; Male ; Medical colleges ; Medical Microbiology ; Medical research ; Medicine, Experimental ; Middle Aged ; Nucleic acids ; Outcome ; Patient Discharge ; Patient outcomes ; Polymerase chain reaction ; Prevalence ; Re-positive ; Retrospective Studies ; Reverse Transcriptase Polymerase Chain Reaction ; RNA, Viral - analysis ; SARS-CoV-2 - genetics ; SARS-CoV-2 - isolation & purification ; Viral diseases ; Viruses
ispartofEuropean journal of clinical microbiology & infectious diseases, 2020-08-31, Vol.40 (2), p.413-417
rights
0Springer-Verlag GmbH Germany, part of Springer Nature 2020
1COPYRIGHT 2021 Springer
2Springer-Verlag GmbH Germany, part of Springer Nature 2020.
lds50peer_reviewed
oafree_for_read
citesFETCH-LOGICAL-c440t-bae03971dfd18dc6012bc81f39b377a056544178904d42d582584043adfef440
orcidid0000-0002-5978-9734
links
openurl$$Topenurl_article
thumbnail$$Usyndetics_thumb_exl
backlink$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/32865669$$D View this record in MEDLINE/PubMed
search
creatorcontrib
0Du, Hou-wei
1Chen, Jun-nian
2Pan, Xiao-bin
3Chen, Xiao-ling
4Yixian-Zhang
5Fang, Shuang-fang
6Li, Xiao-qing
7Xia, Pin-cang
8Gao, Lei
9Lin, Hai-long
10Chen, Li-min
11Liu, Nan
12Fujian Medical Team Support Wuhan for COVID-19
13On behalf of Fujian Medical Team Support Wuhan for COVID-19
title
0Prevalence and outcomes of re-positive nucleic acid tests in discharged COVID-19 patients
1European journal of clinical microbiology & infectious diseases
addtitle
0Eur J Clin Microbiol Infect Dis
1Eur J Clin Microbiol Infect Dis
descriptionThe prevalence and outcomes of patients who had re-activation of coronavirus disease 2019 (COVID-19) after discharge remain poorly understood. We included 126 consecutively confirmed cases of COVID-19 with 2-month follow-up data after discharge in this retrospective study. The upper respiratory specimen using a reverse-transcription polymerase chain reaction test of three patients (71 years [60–76]) were positive within 11–20 days after their discharge, with an event rate of 19.8 (95%CI 2.60–42.1) per 1,000,000 patient-days. Moreover, all re-positive patients were asymptomatic. Our findings suggest that few recovered patients may still be virus carriers even after reaching the discharge criteria.
subject
0Aged
1Biomedical and Life Sciences
2Biomedicine
3Brief Report
4Communicable diseases
5Coronavirus disease 2019
6Coronaviruses
7COVID-19
8COVID-19 - virology
9Female
10Follow-up
11Humans
12Infectivity
13Internal Medicine
14Male
15Medical colleges
16Medical Microbiology
17Medical research
18Medicine, Experimental
19Middle Aged
20Nucleic acids
21Outcome
22Patient Discharge
23Patient outcomes
24Polymerase chain reaction
25Prevalence
26Re-positive
27Retrospective Studies
28Reverse Transcriptase Polymerase Chain Reaction
29RNA, Viral - analysis
30SARS-CoV-2 - genetics
31SARS-CoV-2 - isolation & purification
32Viral diseases
33Viruses
issn
00934-9723
11435-4373
fulltextfalse
rsrctypearticle
creationdate2020
recordtypearticle
recordideNp9kl9rFDEUxYModrv6BXyQgC--TM2_mUxehLJaLRTqQxF8CtnkzjZlNlmTmQW_vbduba2IBBK4-d1zOZdDyCvOTjhj-l3F23QNE6xhignV8CdkwZVsGyW1fEoWzEjVGC3kETmu9YZhU6_1c3IkRd-1XWcW5NuXAns3QvJAXQo0z5PPW6g0D7RAs8s1TnEPNM1-hOip8zHQCepUaUw0xOqvXdlAoKvLr-cfGm7ozk0R0lRfkGeDGyu8vHuX5Ors49Xqc3Nx-el8dXrReKXY1KwdMGk0D0PgffAd42Ltez5Is5ZaO9Z2rVJc94apoERoe9H2iinpwgADKizJ-4Psbl5vIXgcXdxodyVuXflhs4v28U-K13aT91Yr3EDHUODtnUDJ32d0ZrfoCsbRJchztULJ3hjZC4Hom7_QmzyXhO6Q0kYIrrh5oDa4VxvTkHGuvxW1p50ygrdGdEid_IPCE2AbfU4wRKw_ahCHBl9yrQWGe4-c2ds82EMeLObB_soDVpfk9Z_buW_5HQAE5AGo-JU2UB4s_Uf2J_wZvgc
startdate20200831
enddate20200831
creator
0Du, Hou-wei
1Chen, Jun-nian
2Pan, Xiao-bin
3Chen, Xiao-ling
4Yixian-Zhang
5Fang, Shuang-fang
6Li, Xiao-qing
7Xia, Pin-cang
8Gao, Lei
9Lin, Hai-long
10Chen, Li-min
11Liu, Nan
general
0Springer Berlin Heidelberg
1Springer
2Springer Nature B.V
scope
0CGR
1CUY
2CVF
3ECM
4EIF
5NPM
6AAYXX
7CITATION
8BSHEE
93V.
107QL
117U9
127X7
137XB
1488A
1588E
168AO
178FE
188FH
198FI
208FJ
218FK
22ABUWG
23AZQEC
24BBNVY
25BENPR
26BHPHI
27C1K
28DWQXO
29FYUFA
30GHDGH
31GNUQQ
32H94
33HCIFZ
34K9.
35LK8
36M0S
37M1P
38M7N
39M7P
40PQEST
41PQQKQ
42PQUKI
43PRINS
447X8
455PM
orcididhttps://orcid.org/0000-0002-5978-9734
sort
creationdate20200831
titlePrevalence and outcomes of re-positive nucleic acid tests in discharged COVID-19 patients
authorDu, Hou-wei ; Chen, Jun-nian ; Pan, Xiao-bin ; Chen, Xiao-ling ; Yixian-Zhang ; Fang, Shuang-fang ; Li, Xiao-qing ; Xia, Pin-cang ; Gao, Lei ; Lin, Hai-long ; Chen, Li-min ; Liu, Nan
facets
frbrtype5
frbrgroupidcdi_FETCH-LOGICAL-c440t-bae03971dfd18dc6012bc81f39b377a056544178904d42d582584043adfef440
rsrctypearticles
prefilterarticles
languageeng
creationdate2020
topic
0Aged
1Biomedical and Life Sciences
2Biomedicine
3Brief Report
4Communicable diseases
5Coronavirus disease 2019
6Coronaviruses
7COVID-19
8COVID-19 - virology
9Female
10Follow-up
11Humans
12Infectivity
13Internal Medicine
14Male
15Medical colleges
16Medical Microbiology
17Medical research
18Medicine, Experimental
19Middle Aged
20Nucleic acids
21Outcome
22Patient Discharge
23Patient outcomes
24Polymerase chain reaction
25Prevalence
26Re-positive
27Retrospective Studies
28Reverse Transcriptase Polymerase Chain Reaction
29RNA, Viral - analysis
30SARS-CoV-2 - genetics
31SARS-CoV-2 - isolation & purification
32Viral diseases
33Viruses
toplevelpeer_reviewed
creatorcontrib
0Du, Hou-wei
1Chen, Jun-nian
2Pan, Xiao-bin
3Chen, Xiao-ling
4Yixian-Zhang
5Fang, Shuang-fang
6Li, Xiao-qing
7Xia, Pin-cang
8Gao, Lei
9Lin, Hai-long
10Chen, Li-min
11Liu, Nan
12Fujian Medical Team Support Wuhan for COVID-19
13On behalf of Fujian Medical Team Support Wuhan for COVID-19
collection
0Medline
1MEDLINE
2MEDLINE (Ovid)
3MEDLINE
4MEDLINE
5PubMed
6CrossRef
7Academic OneFile (A&I only)
8ProQuest Central (Corporate)
9Bacteriology Abstracts (Microbiology B)
10Virology and AIDS Abstracts
11Health & Medical Collection
12ProQuest Central (purchase pre-March 2016)
13Biology Database (Alumni Edition)
14Medical Database (Alumni Edition)
15ProQuest Pharma Collection
16ProQuest SciTech Collection
17ProQuest Natural Science Collection
18Hospital Premium Collection
19Hospital Premium Collection (Alumni Edition)
20ProQuest Central (Alumni) (purchase pre-March 2016)
21ProQuest Central (Alumni Edition)
22ProQuest Central Essentials
23Biological Science Collection
24ProQuest Central
25Natural Science Collection
26Environmental Sciences and Pollution Management
27ProQuest Central Korea
28Health Research Premium Collection
29Health Research Premium Collection (Alumni)
30ProQuest Central Student
31AIDS and Cancer Research Abstracts
32SciTech Premium Collection
33ProQuest Health & Medical Complete (Alumni)
34ProQuest Biological Science Collection
35Health & Medical Collection (Alumni Edition)
36Medical Database
37Algology Mycology and Protozoology Abstracts (Microbiology C)
38Biological Science Database
39ProQuest One Academic Eastern Edition
40ProQuest One Academic
41ProQuest One Academic UKI Edition
42ProQuest Central China
43MEDLINE - Academic
44PubMed Central (Full Participant titles)
jtitleEuropean journal of clinical microbiology & infectious diseases
delivery
delcategoryRemote Search Resource
fulltextno_fulltext
addata
au
0Du, Hou-wei
1Chen, Jun-nian
2Pan, Xiao-bin
3Chen, Xiao-ling
4Yixian-Zhang
5Fang, Shuang-fang
6Li, Xiao-qing
7Xia, Pin-cang
8Gao, Lei
9Lin, Hai-long
10Chen, Li-min
11Liu, Nan
aucorp
0Fujian Medical Team Support Wuhan for COVID-19
1On behalf of Fujian Medical Team Support Wuhan for COVID-19
formatjournal
genrearticle
ristypeJOUR
atitlePrevalence and outcomes of re-positive nucleic acid tests in discharged COVID-19 patients
jtitleEuropean journal of clinical microbiology & infectious diseases
stitleEur J Clin Microbiol Infect Dis
addtitleEur J Clin Microbiol Infect Dis
date2020-08-31
risdate2020
volume40
issue2
spage413
epage417
pages413-417
issn0934-9723
eissn1435-4373
abstractThe prevalence and outcomes of patients who had re-activation of coronavirus disease 2019 (COVID-19) after discharge remain poorly understood. We included 126 consecutively confirmed cases of COVID-19 with 2-month follow-up data after discharge in this retrospective study. The upper respiratory specimen using a reverse-transcription polymerase chain reaction test of three patients (71 years [60–76]) were positive within 11–20 days after their discharge, with an event rate of 19.8 (95%CI 2.60–42.1) per 1,000,000 patient-days. Moreover, all re-positive patients were asymptomatic. Our findings suggest that few recovered patients may still be virus carriers even after reaching the discharge criteria.
copBerlin/Heidelberg
pubSpringer Berlin Heidelberg
pmid32865669
doi10.1007/s10096-020-04024-1
orcididhttps://orcid.org/0000-0002-5978-9734
oafree_for_read